These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16284142)

  • 1. From the archives of the AFIP: Oligodendroglioma and its variants: radiologic-pathologic correlation.
    Koeller KK; Rushing EJ
    Radiographics; 2005; 25(6):1669-88. PubMed ID: 16284142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.
    Sonabend AM; Lesniak MS
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S25-32. PubMed ID: 16274268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in diagnosis and management of oligodendroglioma.
    Hussein MR; Baidas S
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):520-8. PubMed ID: 12382520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of oligodendroglioma.
    Smits M
    Br J Radiol; 2016; 89(1060):20150857. PubMed ID: 26849038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracranial relapse of an anaplastic oligodendroglioma in an adolescent: case report and review of the literature.
    Bruggers C; White K; Zhou H; Chen Z
    J Pediatr Hematol Oncol; 2007 May; 29(5):319-22. PubMed ID: 17483710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendroglioma.
    Van den Bent MJ; Reni M; Gatta G; Vecht C
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):262-72. PubMed ID: 18272388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of oligodendroglial tumours: current developments.
    van den Bent MJ
    Forum (Genova); 2000; 10(2):108-18. PubMed ID: 10875973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic oligodendroglioma and oligoastrocytoma.
    van den Bent MJ
    Neurol Clin; 2007 Nov; 25(4):1089-109, ix-x. PubMed ID: 17964027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.
    Jenkinson MD; Smith TS; Joyce KA; Fildes D; Broome J; du Plessis DG; Haylock B; Husband DJ; Warnke PC; Walker C
    Neuroradiology; 2006 Oct; 48(10):703-13. PubMed ID: 16937145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis.
    Engelhard HH; Stelea A; Mundt A
    Surg Neurol; 2003 Nov; 60(5):443-56. PubMed ID: 14572971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.
    Qu M; Olofsson T; Sigurdardottir S; You C; Kalimo H; Nistér M; Smits A; Ren ZP
    Acta Neuropathol; 2007 Feb; 113(2):129-36. PubMed ID: 17031656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendroglioma: incidence and biological behavior in a defined population.
    Mørk SJ; Lindegaard KF; Halvorsen TB; Lehmann EH; Solgaard T; Hatlevoll R; Harvei S; Ganz J
    J Neurosurg; 1985 Dec; 63(6):881-9. PubMed ID: 4056902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.
    Jenkinson MD; Smith TS; Joyce K; Fildes D; du Plessis DG; Warnke PC; Walker C
    Neurology; 2005 Jun; 64(12):2085-9. PubMed ID: 15985578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma.
    Cairncross G; Jenkins R
    Cancer J; 2008; 14(6):352-7. PubMed ID: 19060598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
    Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR
    Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
    Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.
    Walker C; du Plessis DG; Fildes D; Haylock B; Husband D; Jenkinson MD; Joyce KA; Broome J; Kopitski K; Prosser J; Smith T; Vinjamuri S; Warnke PC
    Clin Cancer Res; 2004 Nov; 10(21):7182-91. PubMed ID: 15534091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
    Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.